Synlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023 - Synlogic (NASDAQ:SYBX)
- Poster presentation on SYNB1353 program for homocystinuria includes findings from process improvements to improve activity of methionine degradation - CAMBRIDGE, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Synlogic,
United States United Kingdom David Lubkowicz Drug Administration Exchange Commission Program Lead At Synlogic
Source: benzinga.com